AstraZeneca Announces $100 Million R&D Investment in China

New Innovation Centre to Focus Initially on Oncology Research

30-May-2006

AstraZeneca intents to invest $100 million in R&D in China over the next three years, focusing on the benefit and value of innovative medicines for Chinese patients. The prime focus of this programme will be the establishment of the AstraZeneca Innovation Centre China. The company has initiated a comprehensive search for an appropriate location for the Innovation Centre, which will be operational by the end of 2009. The Centre will focus on translational science by developing knowledge about Chinese patients, biomarkers and genetics. The initial therapeutic area for the Innovation Centre will be cancer.

In addition, AstraZeneca will expand its clinical research capabilities and is looking to increase the number of scientific collaborations with local Chinese organisations. AstraZeneca has recently signed a deal worth $14 million with Wuxi Pharmatech for Compound Collection Synthesis and has an existing collaboration with Shanghai Jiao Tong University on the genetics of schizophrenia.

Other news from the department business & finance

Most read news

More news from our other portals

So close that even
molecules turn red...

See the theme worlds for related content

Topic world Synthesis

Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.

15+ products
4 whitepaper
15+ brochures
View topic world
Topic world Synthesis

Topic world Synthesis

Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.

15+ products
4 whitepaper
15+ brochures